- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 209/36 - Atomes d'oxygène en position 3, p. ex. adrénochrome
Détention brevets de la classe C07D 209/36
Brevets de cette classe: 66
Historique des publications depuis 10 ans
|
3
|
7
|
5
|
3
|
2
|
4
|
4
|
2
|
5
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Musc Foundation for Research Development | 356 |
5 |
| Biosynth AG | 63 |
4 |
| Azora Therapeutics, Inc. | 13 |
4 |
| Syntara Limited | 10 |
3 |
| Amira Pharmaceuticals, Inc. | 66 |
2 |
| Beth Israel Deaconess Medical Center, Inc. | 863 |
2 |
| CFD Research Corporation | 58 |
2 |
| National University Corporation Kobe University | 550 |
2 |
| U.S. Department of Veterans Affairs | 50 |
2 |
| New Mexico Tech University Research Park Corporation | 50 |
2 |
| Boehringer Ingelheim International GmbH | 4552 |
1 |
| Centre National de La Recherche Scientifique | 10846 |
1 |
| FUJIFILM Corporation | 30206 |
1 |
| The General Hospital Corporation | 4797 |
1 |
| Georgia Tech Research Corporation | 2893 |
1 |
| The Board of Regents of the University of Oklahoma | 626 |
1 |
| Board of Trustees of Southern Illinois University | 97 |
1 |
| The Broad Institute, Inc. | 1922 |
1 |
| Cambridge Display Technology Limited | 483 |
1 |
| Clark Atlanta University, Inc. | 12 |
1 |
| Autres propriétaires | 28 |